Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)
This study has been terminated.
( Slow Enrollment )
Study NCT00938314 Information provided by Stem Cell Therapeutics Corp.
First Received on July 9, 2009. Last Updated on November 24, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Reproductive Control Agents
Sponsors listed in this trial
Stem Cell Therapeutics Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers